Best practice in asymptomaticcarotid stenosis
             Dr. Pascual Lozano Vilardell
             Angiología y Cirugía Vascular
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Clinical trials




                                    30 days risk                   CEA
                             ACAS                                 2,3%
                             ACST                                 2,8%




   ACAS. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-1428
   Halliday A et al. Prevention of disabling and fatal strokes by successful CEA in patients without recent
   neurologic symptoms: a randomised controlled trial. Lancet 2004;363:1491-1502
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Clinical trials




            5 year risk                   CEA                BMT              RRR              NNT

   ACAS                                  5,1%               11,0%             54%               84
   ACST                                  6,4%               11,8%             46%               70


           10 year risk
   ACST                                 13,4%               17,9%             26%




   ACAS. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-1428
   Halliday A et al. Prevention of disabling and fatal strokes by successful CEA in patients without recent
   neurologic symptoms: a randomised controlled trial. Lancet 2004;363:1491-1502
   Halliday A, et al. 10-year stroke prevention after successful CEA for asymptomatic carotid stenosis
   (ACST-1): a multicenter randomised trial. Lancet 2010;376:1074-1084
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS




        ESVS, SVS, AHA…
        Carotid endarterectomy is indicated in all patients with
        asymptomatic carotid stenosis > 60%, if periprocedural
        rate of death-stroke is < 3%
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
CREST results in asymptomatic




                   CREST ASYMPTOMATIC               periprocedural         4 years
                CEA                                       1,4%              2,7%
                CAS                                       2,5%              4,5%
                Death-stroke. MI excluded




   Brott et al. Stenting versus endarterectomy for treatment of carotid artery stenosis. N Eng J Med
   2010;363:11-13
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
CREST results in asymptomatic




                                                          SVS REGISTRY
                        CEA                                   2,0 %
                        CAS                                   4,6 %
                        Combined death-stroke-MI




   Giles KA et al. Stroke and death after CEA and CAS with and without high risk criteria. J VascSurg
   2010;52:1497-1504
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
2008 survey




   Klein A et al. Management of carotid stenosis- polling results. N Eng J Med 2008,358:e23
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Concerns about revascularization
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Concerns about revascularization




        Marginal surgical benefit (annual ARR 1%)
        Patient selection
        Nature of interventions
        Results “in the real world”
        Reporting methods
        Emerging rol of CAS
        Increased evidence risk of stroke is declining with the
        improvement of BMT




   Abbott AL. Medical intervention alone is now best for prevention of stroke associated with
   asymptomatic severe carotid stenosis. A systematic review. Stroke 2009;573-83
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Recurrent stroke rate 1960-2010




                             8,71%



                                                                        4,04%




   Hong K et al. Declining Stroke and Vascular Events Recurrence Rates in Secondary Prevention Trials.
   Circulation 2011;123:2111-2119
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Recurrent stroke rate 1960-2010




                             Declining of event rates per decade
                   Recurrent stroke                               1,0 %
                   Fatal stroke                                   0,3 %
                   Major vascular events                           1,3%




   Hong K et al. Declining Stroke and Vascular Events Recurrence Rates in Secondary Prevention Trials.
   Circulation 2011;123:2111-2119
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Stroke rates in asymptomatic 1985-2007




                     Stroke type                           time                   Decrease
        Ipsilateral stroke                            1985-2007                     1,7%
        Ipsilateral stroke/TIA                        1985-2005                      7%




   Abbott AL. Medical intervention alone is now best for prevention of stroke associated with
   asymptomatic severe carotid stenosis. Stroke 2009;40:573-583
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Stroke rates in asymptomatic 1985-2007




                         ipsilateral stroke                                 any stroke




   Abbott AL. Medical intervention alone is now best for prevention of stroke associated with
   asymptomatic severe carotid stenosis. Stroke 2009;40:573-583
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Stroke rates in medical arm ACAS and ACST 1985-2010




                                           3,5%


                                                                        2,4%
                                                                                     1,4%
                                           2,2%
                                                                        1,1%
                                                                                     0,7%




   Naylor AR. What is the current status of invasive treatment of extracraneal carotid artery disease?
   Stroke 2011;42:2080-85
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Rate of stroke in asymptomatics




           OXFORD VASCULAR STUDY (2002-2009)

                 101 patients with ACS  BMT

                 Annual ipsilateral stroke rate 0,34%




   Marquardt L et al. Low risk of ipsilateral stroke in patients with ACS on best medical treatment.
   Stroke 2010;41:11-17
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Embolic signals and stroke




         Presence of MES are related to risk of stroke

              90% no MES AAR <1%

              10% with MES                     AAR 15%




   Spence JD et al. Absence of MES on TCD identifies low-risk patients with Asymptomatic Carotid
   Stenosis. Stroke 2005;36:2373-2378
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Embolic signals and stroke




         ACES (Asymptomatic Carotid Emboli Study)

              Prospective multicenter study
              Objective: to detect MES by TCD
              Endpoints: TIA or ipsilateral stroke
              Hypothesis: MES predicts ipsilateral TIA or stroke




   Markus HS et al. Asymptomatic embolisation for prediction of stroke in the ACES: a prospective
   observational study. Lancet Neurol 2010;9:663-671
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Embolic signals and stroke




                                  Patients with MES                   Mean number MES
       Baseline 1                        10%                               2,63 (1-20)
       Baseline 2                        11%                               2,23 (1-11)




   Markus HS et al. Asymptomatic embolisation for prediction of stroke in the ACES: a prospective
   observational study. Lancet Neurol 2010;9:663-671
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Embolic signals and stroke



         32 primary endpoints: 26 TIA, 6 strokes


                           AAR ipsilateral stroke
   MES                              3,62%
   No MES                           0,70%
   HR 2,54 (95%CI 1,20-5,36)




   Markus HS et al. Asymptomatic embolisation for prediction of stroke in the ACES: a prospective
   observational study. Lancet Neurol 2010;9:663-671
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Embolic signals and stroke




         468 patients

               199 (2000-2002)

               269 (2003-2007)  Intensive medical therapy




   Spence JD et al. Effects of Intensive Medical Therapy on Microemboli and Cardiovascular Risk in ACS.
   Arch Neurol 2010;67:180-86
BEST PRACTICE FOR ASYMPTOMATIC CAROTID STENOSIS
Embolic signals and stroke




                     Patients with MES          Carotid plaque           Cardiovascular events

   2000-2002               12,6%                    69 mm2                        17,6%
   2003-2007                3,7%                    23 mm2                         5,6%




   Spence JD et al. Effects of Intensive Medical Therapy on Microemboli and Cardiovascular Risk in ACS.
   Arch Neurol 2010;67:180-86
CONCLUSIONS




       In patients with asymptomatic carotid stenosis

              Risk of stroke is declining over time

              Medical treatment has improved

              Annual risk of stroke on BMT < 1%
CONCLUSIONS




       In patients with asymptomatic carotid stenosis

              There is a subgroup at high risk of stroke

       Wemustidentifythissubgroup
PREDICTION OF STROKE IN ACS




                 Embolic signals on TCD
                 Cerebrovascular reserve
                 Plaque morphology
                 Stenosis progresion rate
                 Serum biomarkers
CONCLUSIONS




       In patients with asymptomatic carotid stenosis

              However, we don’t have level IA evidence of this
              afirmations

              We need clinical trials

Best practice in asymptomatic carotid stenosis

  • 1.
    Best practice inasymptomaticcarotid stenosis Dr. Pascual Lozano Vilardell Angiología y Cirugía Vascular
  • 2.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Clinical trials 30 days risk CEA ACAS 2,3% ACST 2,8% ACAS. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-1428 Halliday A et al. Prevention of disabling and fatal strokes by successful CEA in patients without recent neurologic symptoms: a randomised controlled trial. Lancet 2004;363:1491-1502
  • 3.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Clinical trials 5 year risk CEA BMT RRR NNT ACAS 5,1% 11,0% 54% 84 ACST 6,4% 11,8% 46% 70 10 year risk ACST 13,4% 17,9% 26% ACAS. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-1428 Halliday A et al. Prevention of disabling and fatal strokes by successful CEA in patients without recent neurologic symptoms: a randomised controlled trial. Lancet 2004;363:1491-1502 Halliday A, et al. 10-year stroke prevention after successful CEA for asymptomatic carotid stenosis (ACST-1): a multicenter randomised trial. Lancet 2010;376:1074-1084
  • 4.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS ESVS, SVS, AHA… Carotid endarterectomy is indicated in all patients with asymptomatic carotid stenosis > 60%, if periprocedural rate of death-stroke is < 3%
  • 5.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS CREST results in asymptomatic CREST ASYMPTOMATIC periprocedural 4 years CEA 1,4% 2,7% CAS 2,5% 4,5% Death-stroke. MI excluded Brott et al. Stenting versus endarterectomy for treatment of carotid artery stenosis. N Eng J Med 2010;363:11-13
  • 6.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS CREST results in asymptomatic SVS REGISTRY CEA 2,0 % CAS 4,6 % Combined death-stroke-MI Giles KA et al. Stroke and death after CEA and CAS with and without high risk criteria. J VascSurg 2010;52:1497-1504
  • 7.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS 2008 survey Klein A et al. Management of carotid stenosis- polling results. N Eng J Med 2008,358:e23
  • 8.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Concerns about revascularization
  • 9.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Concerns about revascularization Marginal surgical benefit (annual ARR 1%) Patient selection Nature of interventions Results “in the real world” Reporting methods Emerging rol of CAS Increased evidence risk of stroke is declining with the improvement of BMT Abbott AL. Medical intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis. A systematic review. Stroke 2009;573-83
  • 10.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Recurrent stroke rate 1960-2010 8,71% 4,04% Hong K et al. Declining Stroke and Vascular Events Recurrence Rates in Secondary Prevention Trials. Circulation 2011;123:2111-2119
  • 11.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Recurrent stroke rate 1960-2010 Declining of event rates per decade Recurrent stroke 1,0 % Fatal stroke 0,3 % Major vascular events 1,3% Hong K et al. Declining Stroke and Vascular Events Recurrence Rates in Secondary Prevention Trials. Circulation 2011;123:2111-2119
  • 12.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Stroke rates in asymptomatic 1985-2007 Stroke type time Decrease Ipsilateral stroke 1985-2007 1,7% Ipsilateral stroke/TIA 1985-2005 7% Abbott AL. Medical intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis. Stroke 2009;40:573-583
  • 13.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Stroke rates in asymptomatic 1985-2007 ipsilateral stroke any stroke Abbott AL. Medical intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis. Stroke 2009;40:573-583
  • 14.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Stroke rates in medical arm ACAS and ACST 1985-2010 3,5% 2,4% 1,4% 2,2% 1,1% 0,7% Naylor AR. What is the current status of invasive treatment of extracraneal carotid artery disease? Stroke 2011;42:2080-85
  • 15.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Rate of stroke in asymptomatics OXFORD VASCULAR STUDY (2002-2009) 101 patients with ACS  BMT Annual ipsilateral stroke rate 0,34% Marquardt L et al. Low risk of ipsilateral stroke in patients with ACS on best medical treatment. Stroke 2010;41:11-17
  • 16.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Embolic signals and stroke Presence of MES are related to risk of stroke 90% no MES AAR <1% 10% with MES AAR 15% Spence JD et al. Absence of MES on TCD identifies low-risk patients with Asymptomatic Carotid Stenosis. Stroke 2005;36:2373-2378
  • 17.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Embolic signals and stroke ACES (Asymptomatic Carotid Emboli Study) Prospective multicenter study Objective: to detect MES by TCD Endpoints: TIA or ipsilateral stroke Hypothesis: MES predicts ipsilateral TIA or stroke Markus HS et al. Asymptomatic embolisation for prediction of stroke in the ACES: a prospective observational study. Lancet Neurol 2010;9:663-671
  • 18.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Embolic signals and stroke Patients with MES Mean number MES Baseline 1 10% 2,63 (1-20) Baseline 2 11% 2,23 (1-11) Markus HS et al. Asymptomatic embolisation for prediction of stroke in the ACES: a prospective observational study. Lancet Neurol 2010;9:663-671
  • 19.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Embolic signals and stroke 32 primary endpoints: 26 TIA, 6 strokes AAR ipsilateral stroke MES 3,62% No MES 0,70% HR 2,54 (95%CI 1,20-5,36) Markus HS et al. Asymptomatic embolisation for prediction of stroke in the ACES: a prospective observational study. Lancet Neurol 2010;9:663-671
  • 20.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Embolic signals and stroke 468 patients 199 (2000-2002) 269 (2003-2007)  Intensive medical therapy Spence JD et al. Effects of Intensive Medical Therapy on Microemboli and Cardiovascular Risk in ACS. Arch Neurol 2010;67:180-86
  • 21.
    BEST PRACTICE FORASYMPTOMATIC CAROTID STENOSIS Embolic signals and stroke Patients with MES Carotid plaque Cardiovascular events 2000-2002 12,6% 69 mm2 17,6% 2003-2007 3,7% 23 mm2 5,6% Spence JD et al. Effects of Intensive Medical Therapy on Microemboli and Cardiovascular Risk in ACS. Arch Neurol 2010;67:180-86
  • 22.
    CONCLUSIONS In patients with asymptomatic carotid stenosis Risk of stroke is declining over time Medical treatment has improved Annual risk of stroke on BMT < 1%
  • 23.
    CONCLUSIONS In patients with asymptomatic carotid stenosis There is a subgroup at high risk of stroke Wemustidentifythissubgroup
  • 24.
    PREDICTION OF STROKEIN ACS Embolic signals on TCD Cerebrovascular reserve Plaque morphology Stenosis progresion rate Serum biomarkers
  • 25.
    CONCLUSIONS In patients with asymptomatic carotid stenosis However, we don’t have level IA evidence of this afirmations We need clinical trials